Digitala Vetenskapliga Arkivet

Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
Do the new signal transduction modulators have activity in vitro in tumor cells from ovarian carcinoma and lymphoma?
Uppsala University, Medicinska vetenskapsområdet, Faculty of Medicine, Department of Medical Biochemistry and Microbiology.
2005 (English)Independent thesis Basic level (degree of Bachelor), 10 credits / 15 HE creditsStudent thesis
Abstract [en]

During the last decades, chemotherapy with cytotoxic drugs has played a significant role in cancer therapy. It’s important to develop new anticancer drugs, and drug sensitivity testing in vitro can be used to find the right diagnosis for the newly developed substances.

The aim of this study was to investigate the cytotoxic activity of the new signal transduction modulators bortezomib, gefitinib and PKC412. The well-established substances cisplatin, cytarabine, doxorubicin and vincristin were investigated for comparison.

The activity of the cytotoxic drugs was analysed in human tumor samples from patients with ovarian carcinoma (n=16) and lymphoma (n=15) by using the Fluorometric Microculture Cytotoxicity Assay (FMCA). The testing of cellular drug resistance by FMCA was accomplished successfully in 33 out of the 34 samples (97%).

The results of this study indicated that the activity of cytotoxic drugs in tumor cells obtained from patients with ovarian carcinoma and lymphoma may be detected by the FMCA. It also suggested that bortezomib and gefitinib could represent promising agents for treatment of ovarian carcinoma and that PKC412 might be of less use for patients with this diagnose.

Place, publisher, year, edition, pages
2005. , p. 24
Keywords [en]
Anticancer drug development, ovarian carcinoma, lymphoma, FMCA, cytotoxic drugs, in vitro assay
National Category
Medical Bioscience
Identifiers
URN: urn:nbn:se:uu:diva-6158OAI: oai:DiVA.org:uu-6158DiVA, id: diva2:130394
Uppsok
lantbruk/veterinärmed./skogl. vetenskap
Supervisors
Examiners
Available from: 2005-11-02 Created: 2005-11-02

Open Access in DiVA

fulltext(275 kB)1169 downloads
File information
File name FULLTEXT01.pdfFile size 275 kBChecksum SHA-1
174e93a093eee8f5974460eac674beaa679c06f02f5e0f32dcb4f8520d7c4aafda7abe20
Type fulltextMimetype application/pdf

By organisation
Department of Medical Biochemistry and Microbiology
Medical Bioscience

Search outside of DiVA

GoogleGoogle Scholar
Total: 1169 downloads
The number of downloads is the sum of all downloads of full texts. It may include eg previous versions that are now no longer available

urn-nbn

Altmetric score

urn-nbn
Total: 1372 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf